Siemens Healthineers AG SHL
XETR · Germany · Health Technology
€37.55-0.42 (-1.11%)
Market open· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Both companies are years from commercial scale and burning cash to get there. The difference is in how long each can keep going.
Opportunities center on automated, standardized TDM kits integrated with AI dosing tools for antimicrobial stewardship, transplant care and precision medicine, especially in Asia-Pacific.Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "TDM Reagent Kit Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. This market research report examines the global TDM Reagent Kit Market, projected to reach USD 2.87 billion in 2026 and grow at a CAGR of 15.84% to USD 6.96 billion
Siemens Healthineers (XTRA:SHL) and Novo announced a new collaboration to address MASLD and MASH using non-invasive diagnostics. The partnership focuses on expanding disease awareness and clinical use of less invasive tools for assessing liver health and progression risk. Both groups aim to support earlier identification of at-risk patients, potentially affecting how metabolic liver conditions are managed in routine care. The Siemens Healthineers and Novo MASLD and MASH collaboration is...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.